Literature DB >> 17890357

Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.

Amita Shukla-Dave1, Hedvig Hricak, Chaya Moskowitz, Nicole Ishill, Oguz Akin, Kentaro Kuroiwa, Jessica Spector, Mahesh Kumar, Victor E Reuter, Jason A Koutcher, Kristen L Zakian.   

Abstract

PURPOSE: To characterize benign and malignant prostate peripheral zone (PZ) tissue retrospectively by using a commercial magnetic resonance (MR) spectroscopic imaging package and incorporating the choline plus creatine-to-citrate ratio ([Cho + Cr]/Cit) and polyamine (PA) information into a statistically based voxel classification procedure.
MATERIALS AND METHODS: The institutional review board approved this HIPAA-compliant study and waived the requirement for informed consent. Fifty men (median age, 60 years; range, 44-69 years) with untreated biopsy-proved prostate cancer underwent combined endorectal MR imaging and MR spectroscopic imaging. Commercial software was used to acquire and process MR spectroscopic imaging data. The (Cho + Cr)/Cit and the PA level were tabulated for each voxel. The PA level was scored on a scale of 0 (PA undetectable) to 2 (PA peak as high as or higher than Cho peak). Whole-mount step-section histopathologic analysis constituted the reference standard. Classification and regression tree analysis in a training set generated a decision-making tree (rule) for classifying voxels as malignant or benign, which was validated in a test set. Receiver operating characteristic and generalized estimating equation regression analyses were used to assess accuracy and sensitivity, respectively.
RESULTS: The median (Cho + Cr)/Cit was 0.55 (mean +/- standard deviation, 0.59 +/- 0.03) in benign and 0.77 (mean, 1.08 +/- 0.20) in malignant PZ voxels (P = .027). A significantly higher percentage of benign (compared with malignant) voxels had higher PA than choline peaks (P < .001). In the 24-patient training set (584 voxels), the rule yielded 54% sensitivity and 91% specificity for cancer detection; in the 26-patient test set (667 voxels), it yielded 42% sensitivity and 85% specificity. The percentage of cancer in the voxel at histopathologic analysis correlated positively (P < .001) with the sensitivity of the classification and regression tree rule, which was 75% in voxels with more than 90% malignancy.
CONCLUSION: The statistically based classification rule developed indicated that PAs have an important role in the detection of PZ prostate cancer. With commercial software, this method can be applied in clinical settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890357     DOI: 10.1148/radiol.2452062201

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

1.  [Urological update seminar "UroUpdate". Comprehensive 2-day course in continuing education].

Authors:  U Ayazpoor
Journal:  Urologe A       Date:  2008-05       Impact factor: 0.639

2.  [Imaging diagnostics of the prostate].

Authors:  D J Dinter; A M Weidner; F Wenz; A E Pelzer; M S Michel; S O Schoenberg
Journal:  Urologe A       Date:  2010-08       Impact factor: 0.639

3.  Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling.

Authors:  Amita Shukla-Dave; Mireia Castillo-Martin; Ming Chen; Jose Lobo; Nataliya Gladoun; Ana Collazo-Lorduy; Faisal M Khan; Vladimir Ponomarev; Zhengzi Yi; Weijia Zhang; Pier P Pandolfi; Hedvig Hricak; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2016-10-19       Impact factor: 4.307

Review 4.  Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.

Authors:  Martin Umbehr; Lucas M Bachmann; Ulrike Held; Thomas M Kessler; Tullio Sulser; Dominik Weishaupt; John Kurhanewicz; Johann Steurer
Journal:  Eur Urol       Date:  2008-10-18       Impact factor: 20.096

Review 5.  New horizons in prostate cancer imaging.

Authors:  Gregory Ravizzini; Baris Turkbey; Karen Kurdziel; Peter L Choyke
Journal:  Eur J Radiol       Date:  2008-11-07       Impact factor: 3.528

Review 6.  Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer.

Authors:  Michael A Jacobs; Ronald Ouwerkerk; Kyle Petrowski; Katarzyna J Macura
Journal:  Top Magn Reson Imaging       Date:  2008-12

Review 7.  Imaging techniques for prostate cancer: implications for focal therapy.

Authors:  Baris Turkbey; Peter A Pinto; Peter L Choyke
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

Review 8.  Imaging localized prostate cancer: current approaches and new developments.

Authors:  Baris Turkbey; Paul S Albert; Karen Kurdziel; Peter L Choyke
Journal:  AJR Am J Roentgenol       Date:  2009-06       Impact factor: 3.959

Review 9.  Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.

Authors:  John V Hegde; Robert V Mulkern; Lawrence P Panych; Fiona M Fennessy; Andriy Fedorov; Stephan E Maier; Clare M C Tempany
Journal:  J Magn Reson Imaging       Date:  2013-05       Impact factor: 4.813

Review 10.  MR imaging of the prostate in clinical practice.

Authors:  Yousef Mazaheri; Amita Shukla-Dave; Ada Muellner; Hedvig Hricak
Journal:  MAGMA       Date:  2008-09-16       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.